StockTipsArenaBeta

BUY Neuland Laboratories Limited — Ansh Jogendra Bhilwar

BUYNeuland Laboratories Limited
Neuland Laboratories share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: Intraday11 Nov 2026, 7:34 am ISTvia Zee Business (Live)

Entry₹20,325Inferred
Target₹21,250
Total upside +4.55% (call closed)
Stop loss₹19,860-2.29% risk
Exit₹19,86011 Nov 2026, 9:16 am
Stop-loss hit-2.29%
Follow Ansh Jogendra Bhilwar for new calls(16% target hit, 150 closed calls)Get alertsWatch NEULANDLAB for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Nov 2026
3 supporting4 opposing
Supports the BUY call (3)

Neuland Laboratories Limited sees peptide pipeline double

NewsGoogle News·6 Nov · 4d ago

(opens in new tab)

Neuland sees no meaningful CMS patent expiries before 2030

NewsGoogle News·6 Nov · 4d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·2 Nov · 1w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (4)

Neuland says larger molecules may prolong CDMO lumpiness

NewsGoogle News·6 Nov · 4d ago

(opens in new tab)

Neuland Laboratories Limited Just Missed Revenue By 9.3%: Here's What Analysts Think Will Happen Next

NewsGoogle News·6 Nov · 5d ago

(opens in new tab)

Neuland Laboratories September profit falls 47% on sales decline

NewsGoogle News·5 Nov · 5d ago

(opens in new tab)

Neuland Labs Q2 FY27: Revenue Falls 12.6%, Net Profit Declines 46.7% as Margins Contract

NewsGoogle News·4 Nov · 6d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Neuland Laboratories

All analyst calls on Neuland Laboratories

More from Ansh Jogendra Bhilwar

Every call and its outcome